<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
AZN
AstraZeneca
$
()


  • AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage

    Today - 05:52am
  • AstraZeneca reports Q1 core EPS $2.06, consensus $1.22

    Today - 05:49am
  • AstraZeneca put volume heavy and directionally bearish

    4/23/2024 - 11:16am
  • AstraZeneca reports Voydeya approved in EU as PNH add-on treatment

    4/23/2024 - 06:30am
  • Unusually active option classes on open April 18th

    4/18/2024 - 09:41am
  • AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)

    4/16/2024 - 12:49pm
  • AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC

    4/16/2024 - 07:12am
  • AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial

    4/16/2024 - 06:20am
  • What You Missed On Wall Street On Thursday

    4/11/2024 - 16:23pm
  • What You Missed On Wall Street This Morning

    4/11/2024 - 12:02pm
  • AstraZeneca announces FDA approval for Fasenra

    4/11/2024 - 07:05am
  • AstraZeneca increases 2024 dividend by 7% to $3.10 per share

    4/11/2024 - 06:14am
  • Roche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx

    4/10/2024 - 05:23am
  • Nuvectis says NXP900 demonstrates robust activity in NSCLC

    4/8/2024 - 08:41am
  • ENHERTU approved for treatment of unresectable or metastatic HER2 positive

    4/7/2024 - 06:04am
dynamic_feed Breaking News